Table 8.

How I treat women with bleeding disorders.

Management: General Considerations
  1. Take a careful history, perform a physical exam, and obtain laboratory tests

  2. Formulate a treatment plan for current, future bleeding problems

  3. Individualize and optimize menorrhagia treatment plan with help of gynecologist

  4. Test family members

  5. Perform DDAVP testing to establish response

  6. Vaccinate with hepatitis A, B vaccines, if not previously vaccinated

  7. Review bleeding risks associated with aspirin, NSAIDs, other analgesics

  8. Review perioperative recommendations with patient and medical team

  9. Review potential risks of delayed postpartum and postsurgical bleeding

  10. Assist medical team in evaluation of symptoms, and patient in navigation of medical system

 
Treatment: Hemostatic Agents
  1. Consider mid-dose estrogens for initial treatment of menorrhagia

  2. Use DDAVP as first-line therapy for VWD—tachyphylaxis, inconvenience limitations

  3. Use VWF-containing concentrates in those failing DDAVP or requiring longer treatment

  4. Consider antifibrinolytic agents as adjuncts to estrogen or DDAVP for bleeding

  5. Avoid cryoprecipitate because of potential transmissible agent risk

  6. Avoid heparin, aspirin, NSAIDs, and platelet inhibitory agents

  7. Evaluate for iron deficiency when there is menorrhagia or prolonged post-procedure bleeding

  8. Evaluate factor levels in the 8th month of pregnancy to determine peripartum treatment plan

 
Management: General Considerations
  1. Take a careful history, perform a physical exam, and obtain laboratory tests

  2. Formulate a treatment plan for current, future bleeding problems

  3. Individualize and optimize menorrhagia treatment plan with help of gynecologist

  4. Test family members

  5. Perform DDAVP testing to establish response

  6. Vaccinate with hepatitis A, B vaccines, if not previously vaccinated

  7. Review bleeding risks associated with aspirin, NSAIDs, other analgesics

  8. Review perioperative recommendations with patient and medical team

  9. Review potential risks of delayed postpartum and postsurgical bleeding

  10. Assist medical team in evaluation of symptoms, and patient in navigation of medical system

 
Treatment: Hemostatic Agents
  1. Consider mid-dose estrogens for initial treatment of menorrhagia

  2. Use DDAVP as first-line therapy for VWD—tachyphylaxis, inconvenience limitations

  3. Use VWF-containing concentrates in those failing DDAVP or requiring longer treatment

  4. Consider antifibrinolytic agents as adjuncts to estrogen or DDAVP for bleeding

  5. Avoid cryoprecipitate because of potential transmissible agent risk

  6. Avoid heparin, aspirin, NSAIDs, and platelet inhibitory agents

  7. Evaluate for iron deficiency when there is menorrhagia or prolonged post-procedure bleeding

  8. Evaluate factor levels in the 8th month of pregnancy to determine peripartum treatment plan

 
Close Modal

or Create an Account

Close Modal
Close Modal